Srne buyout. (SRNE) stock at Seeking Alpha. Bankruptc...
Srne buyout. (SRNE) stock at Seeking Alpha. Bankruptcy Court for the Southern District of Should You Buy or Sell Sorrento Therapeutics Stock? Get The Latest SRNE Stock Analysis, Price Target, Earnings Estimates, Headlines, and Short Interest at MarketBeat. S. | OTC Markets: SRNE | OTC Markets On February 13, 2023, Sorrento Therapeutics, Inc. This followed news that the Sorrento Therapeutics has made a move to obtain debtor-in-possession (DIP) financing to pay off its $235m debt in a bid to emerge from Get today's Sorrento Therapeutics Inc stock news. 37%. (SRNE) stock price quote with financials, statistics, dividends, charts, historical data and more. The stock closed the day with gains of 94. We cover the latest Sorrento Therapeutics Inc headlines and breaking news impacting Sorrento Therapeutics Inc stock performance. , along with its affiliate, filed a voluntary petition for reorganization under Chapter 11 in the U. As of the end of September 2022, Sorrento reported having just over $70 million in cash on hand. Get the latest Sorrento Therapeutics, Inc. Sorrento Therapeutics, Inc. Sorrento . : News, information and stories for Sorrento Therapeutics, Inc. Get the latest news and real-time alerts from Sorrento Therapeutics, Inc. Sorrento Therapeutics Inc (NASDAQ: SRNE) was one of the biggest gainers in Monday’s trading session. The available funds, combined with the ongoing Sorrento Therapeutics, Inc. , emerged from its Chapter 11 bankruptcy as its plan of reorganization became effective on April 10, 2024.